Medical News

RSS

Laxai Pharma purchases OSR Solutions CRO for $3.6M

Laxai Pharma, Ltd. today announced that it has completed its first acquisition in the clinical research services space by purchasing all of the assets of OSR Solutions, Inc., a New Jersey based contract research organization, for $3.6 million consisting of the following: $1.5mm in cash, $0.75mm in notes, $0.60mm in assumed liabilities, and 5.6mm common shares of Laxai Pharma, Ltd. -- about 10% of the issued and outstanding common shares at closing. The acquisition was financed by a combination of debt and equity.

12 Mar 2010

KHN column -- Public reverse mortgages and long-term care: Can they work together?

In his latest Kaiser Health News column, Howard Gleckman writes: "Here's the problem: By the time we need long-term care services we often don't have readily available resources to pay for them.

12 Mar 2010

Democrats close to health bill deal as some Democrats - and all Republicans - hold out

Congressional Democrats, reportedly closing in on a final health reform agreement, are seeking to alleviate concerns of reluctant members.

12 Mar 2010

Boston Scientific's Express LD Iliac Premounted Stent System for use in iliac arteries receives FDA approval

Boston Scientific Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved its Express® LD Iliac Premounted Stent System for use in iliac arteries. The Express LD Iliac Stent is the first and only low-profile, premounted, balloon-expandable stent approved by the FDA for use in treating iliac artery disease. The Company said it plans to launch the product immediately in the United States.

12 Mar 2010

bioMerieux introduces FDA cleared chromID VRE for detecting Enterococcus faecium and Enterococcus faecalis

bioMerieux – a world leader in the field of in vitro diagnostics – today announced the launch of the first Food and Drug Administration (FDA) cleared chromID™ VRE, a simple and cost-effective solution in the struggle against vancomycin-resistant enterococci (VRE). chromID VRE is the first to receive an FDA 510(k) clearance for the qualitative detection of Enterococcus faecium and Enterococcus faecalis showing acquired resistance to vancomycin in stool specimens.

12 Mar 2010

Hamilton Health Sciences establishes new research facility

Hamilton's role as one of the world's leading centres in cardiac, vascular and stroke research was amplified today with the grand opening of the David Braley Cardiac, Vascular and Stroke Research Institute at the Hamilton General Hospital site of Hamilton Health Sciences.

12 Mar 2010

Senate passes extension of COBRA, other unemployment benefits

The Senate passed a $140 billion "jobs bill" Wednesday that will extend unemployment coverage, increase federal Medicaid funding, block cuts to physician pay and preserve numerous tax breaks and credits that would have expired without congressional action, The Christian Science Monitor reports. "Jobs trump the national debt. That's the message from a robust, bipartisan Senate vote…" (Chaddock, 3/10).

12 Mar 2010

PhRMA spends $6.3 million lobbying in fourth quarter, slight increase from year before

The Pharmaceutical Research and Manufacturers of America spent $6.3 million lobbying Congress and other government arms on health care in the fourth quarter of 2009, The Associated Press reports. PhRMA "spent just 2 percent more than the $6.17 million it paid out for lobbying in the year-ago period.

12 Mar 2010

Novel mutation in gene encoding ankyrin-B increases risk of type 2 diabetes

Alterations in our response to the taste or smell of food may be another culprit responsible for Type 2 diabetes, according to scientists at Duke University Medical Center who have identified the specific mechanism in human specimens and in mice.

12 Mar 2010

TGen, Virginia G. Piper Cancer Center and Side-Out Foundation team up for breast cancer study

Many women live with breast cancer that does not respond to standard medical treatment, a condition that researchers at the Virginia G. Piper Cancer Center at Scottsdale Healthcare want to change by aggressively targeting specific genes.

12 Mar 2010

Traumatic brain injuries may lead to life-threatening complications

One of the most common questions I am asked after someone hits their head is, "How serious is this bump on my head and should I make an appointment?" Head injuries are the result of trauma to the scalp, skull or brain. Concussion, the most common type of traumatic brain injury (TBI), is an injury that occurs after a blow to the head and results in a temporary loss of consciousness.

12 Mar 2010

Does Medicare 'doughnut hole' spur increase in foreign drug imports?

Medill Reports: "Unless federal legislation closes the Medicare coverage gap colloquially known as the 'doughnut hole,' seniors may opt for online drug imports to alleviate steep prescription costs. ... 'As seniors start falling into the doughnut hole, they are going online to find deals on prescription drugs, whether they're based in the U.S. or in other countries,' said Gabriel Levitt, vice president of PharmacyChecker.com LLC, a leader in the evaluation of online and mail-order pharmacies in both the U.S. and abroad.

12 Mar 2010

Baxter International, DVC present Phase III clinical efficacy data for PREFLUCEL

Baxter International Inc., in conjunction with DynPort Vaccine Company LLC, a CSC Company, today presented Phase III study data measuring the clinical efficacy for PREFLUCEL, a trivalent seasonal influenza candidate vaccine. PREFLUCEL is made using Baxter’s Vero cell culture platform and does not contain an adjuvant or preservatives. The data were presented at the International Congress on Infectious Disease (ICID) in Miami, Florida.

From Baxter International Inc. 12 Mar 2010

WHO welcomes Gates Foundation support in advancing global vaccine efforts

WHO welcomes the Bill & Melinda Gates Foundation pledge of US$ 10 billion over the next ten years to accelerate global vaccine efforts.

12 Mar 2010

Sebelius attacks health insurers, they fight back

Health and Human Services Secretary Kathleen Sebelius "pleaded with insurance companies on Wednesday to scrap their campaign against President Obama's health care bill and to work with the White House to pass it," The New York Times reports.

12 Mar 2010

HTDS receives Registration Certificate for MEVAC-Vari vaccine in Guatemala

Hard to Treat Diseases and its subsidiary Mellow Hope announce that the company received Registration Certificate for its MEVAC-Vari vaccine in Guatemala.

12 Mar 2010

Powerful Catholic quietly shaping abortion, health bill debate

Kaiser Health News reports on Richard Doerflinger, who doesn't look the part of a high-powered political strategist. Bearded and bespectacled, he works in a small, cluttered office out of one of Washington's less fashionable neighborhoods, far from the lobbying bastions of K Street.

12 Mar 2010

Medical News

Laxai Pharma purchases OSR Solutions CRO for $3.6M

KHN column -- Public reverse mortgages and long-term care: Can they work together?

Democrats close to health bill deal as some Democrats - and all Republicans - hold out

Boston Scientific's Express LD Iliac Premounted Stent System for use in iliac arteries receives FDA approval

bioMerieux introduces FDA cleared chromID VRE for detecting Enterococcus faecium and Enterococcus faecalis

Hamilton Health Sciences establishes new research facility

Senate passes extension of COBRA, other unemployment benefits

PhRMA spends $6.3 million lobbying in fourth quarter, slight increase from year before

Novel mutation in gene encoding ankyrin-B increases risk of type 2 diabetes

TGen, Virginia G. Piper Cancer Center and Side-Out Foundation team up for breast cancer study

Traumatic brain injuries may lead to life-threatening complications

Does Medicare 'doughnut hole' spur increase in foreign drug imports?

Baxter International, DVC present Phase III clinical efficacy data for PREFLUCEL

WHO welcomes Gates Foundation support in advancing global vaccine efforts

Sebelius attacks health insurers, they fight back

HTDS receives Registration Certificate for MEVAC-Vari vaccine in Guatemala

Powerful Catholic quietly shaping abortion, health bill debate

In addition to anal and cervical cancer, HPV can also cause head and neck cancer

Azur Pharma to acquire PRIALT analgesic therapy from Elan Pharmaceuticals

Hospitals cope with losing money

Building quality into drug development for safer, faster medicines

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Latest News